Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

CoDiagnostics, Inc. (CODX Quick Quote CODX - Free Report) shares ended the last trading session 9.7% higher at $8.62. The jump came on an impressive volume with a higher-than-average number of shares ...

The Covid-19 virus is being called a black swan event. I’m not sure it meets all the criteria. After all, this isn’t the first virus from China that the world has had to confront. But it is a ...

The molecular diagnostics firm revealed it has signed a Memorandum of Understanding with a Saudi Arabian partner to potentially create a joint venture aimed at developing and distributing its Co-Dx™ ...

CODX received its first issued patent for the Co-Dx PCR platform from the Australian Patent Office. CODX's patent covers the PCR Pro instrument and proprietary test cups for point-of-care use. CODX is ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is CoDiagnostics, Inc. (CODX) one of those stocks right now? A ...

New York City, Dec. 19, 2019 (GLOBE NEWSWIRE) -- The CEO of Co-Diagnostics, Inc. (Nasdaq: CODX), a biotech with a patented platform for the development of molecular diagnostic tests that has been ...

CoDiagnostics, Inc. (CODX) closed at $25.73 in the latest trading session, marking a -1.61% move from the prior day. This move lagged the S&P 500's daily gain of 0.06%. Meanwhile, the Dow gained 0.17% ...